Abstract The aim of this study was to assess the clinical spectrum of immunorestitution disease (IRD) in hospitalized patients over a 12-month period. In nine of 18 patients who presented with clinical deterioration during reduction or cessation of immunosuppressants (np6) or bone marrow engraftment (np3), IRD cases included the following infections: scabies infestation (np1); gastric strongyloidiasis (np1); hepatosplenic candidiasis (np1); methicillin-resistant Staphylococcus aureus abscess formation (np2); polyomavirus-related hemorrhagic cystitis (np3); and influenza A pneumonitis (np1). Immunopathological damage during withdrawal of immunosuppression is an incidental way to uncover an asymptomatic infectious disease. Serial monitoring of hematological and clinical profiles is essential in making a diagnosis of IRD.
Introduction
Immunorestitution disease (IRD) was initially described when symptomatic expression or paradoxical deterioration of pre-existing infectious diseases including cytomegalovirus retinitis, pulmonary or extrapulmonary tuberculosis, atypical mycobacterial lymphadenitis, and cryptococcal infection were observed in HIV-positive patients with recovery of the CD4 c lymphocyte count after highly active antiretroviral therapy (HAART) was started [1] . However, the concept of IRD involving innate and adaptive immunity was subsequently formulated when a similar phenomenon occurred in immunosuppressed patients without HIV. In this group, opportunistic infections appeared after dosage reduction or withdrawal of steroid, recovery of the absolute neutrophil count (ANC) from cytotoxic therapy, or engraftment after bone marrow transplantation (BMT) [2] . Despite these reports, the true incidence and clinical spectrum of IRD in daily practice have not been documented. Clinicians are generally unaware of this emerging disease entity, and its nonspecific clinical signs and symptoms and lack of a standard diagnostic laboratory have hindered its understanding. Therefore, we conducted a prospective study to evaluate the extent to which IRDs are encountered in our inpatient consultative service.
Materials and Methods
Data were collected prospectively over a 12-month period (January 1999-December 1999) on patients referred for infectious disease consultation in a tertiary hospital (Queen Mary Hospital, Hong Kong, a 1,350-bed teaching hospital). For the purpose of this study, patients who had received immunosuppressive therapy (systemic steroid, cytotoxic agents, or a combination of steroid and cytotoxic agents) or undergone BMT (conditioning regimen including cytotoxic and/or total body irradiation) that resulted in an ANC of less than 500/ml or an absolute lymphocyte count (ALC) of less than 1,500/ml were defined as immunosuppressed hosts. IRD is defined as an acute symptomatic illness or paradoxical deterioration of a (presumably) pre-existing infection. The illness is temporally related to the recovery of the immune system and is due to immunopathological damage associated with one of the following: (i) the reversal of immunosuppressive processes such as withdrawal of steroid, (ii) recovery of the ANC from chemotherapy, or (iii) engraftment after BMT. The pre-existing microbial infection can be either asymptomatic or mildly symptomatic.
The handling procedure for consultations has been described previously [3, 4] . In addition to performing a detailed history and physical examination, a review of case notes, the dosing regimen of immunosuppressive therapy, and the exact timing of dosage reduction or withdrawal of immunosuppressants were noted for immunosuppressed patients. The time interval between reduction or withdrawal of immunosuppressive therapy, recovery of ANC after cytotoxic agents, or engraftment after BMT and onset of clinical symptoms of IRD was also recorded.
Results and Discussion
There were 2,225 inpatient infectious disease consultations during the study period, of which 280 (12.6%) patients (median age 45 years, range 1-83 years) were undergoing immunosuppressive therapy. Eighteen (6.4%) patients experienced onset or worsening of their clinical symptoms when their immunosuppressant doses were reduced or withdrawn. IRD was documented in nine (50%) of these patients. The clinical details of these cases are listed in Table 1 .
Case 1 was a 12-year-old boy who presented with pruritic lesions over the external genitalia 4 days after the engraftment of neutrophil following allogeneic BMT for dyskeratosis congenita. He developed neutropenic fever and was started on empirical intravenous ceftazidime and amikacin. He engrafted on day 13 with a total leukocyte count of 1,630/ml, ANC 880/ml, ALC 390/ml and absolute monocyte count (AMC) 260/ ml. During the postengraftment period, his ANC progressively increased from 880/ml to 4,450/ml and AMC from 260/ml to 1,410/ml on day 13 to 16, respectively. On day 17, while his ANC was 2,140/ml and AMC 1,020/ml, he was noted to have multiple pruritic erythematous nodules on his penis and scrotum. A skin biopsy on day 21 demonstrated nonspecific histiocytic aggregation and lymphoplasmacytic infiltration in dermal and epidermal layers, but no apoptotic bodies suggestive of cutaneous graft-versus-host disease were noted. As a wet mount of the skin scraping confirmed the presence of Sarcoptes scabiei, a diagnosis of postengraftment scabies was made. He was treated with a standard regimen of topical benzyl benzoate for 2 days with satisfactory clinical improvement. Contact tracing of family members revealed that his younger brother who used to sleep with the patient had also suffered from the same disease 3 weeks before the patient underwent BMT.
Case 2 was a 42-year-old woman with a history of lupus nephritis who received long-term steroid and azathioprine. She was admitted for surgical management of necrotizing fasciitis of her right lower limb. She improved after radical surgical debridement and a combination of intravenous antibiotic therapy that included amoxicillin-clavulanate and ofloxacin. During her convalescent phase, the dose of prednisolone was reduced from 60 mg qd to 15 mg qd over 29 days, while her absolute eosinophil count (AEC) increased from 30/ml to 1,100/ml and ALC increased from 560/ml to 1,800/ml, respectively. While the AEC and ALC levels were at their highest, she developed severe epigastric cramping abdominal pain and diarrhea. An upper endoscopy showed evidence of antral gastritis and duodenitis. Antral biopsy demonstrated multiple Strongyloides larvae in the gastric mucosa with inflammatory and eosinophilic infiltration. IRD due to preexisting gastric strongyloidiasis upon withdrawal of steroid therapy was diagnosed, and she was treated with oral albendazole 400 mg qd for 7 days.
Case 7 was a 39-year-old man receiving high dose cyclophosphamide (120 mg/kg) and total body irradiation (12 Gy) as preconditioning therapy for autologous BMT for diffuse large cell lymphoma (stage 1A). He had an uneventful course during the pre-engraftment phase. Surveillance cultures for microbiological examination including surface swabs, urine culture, stool culture, and blood culture were collected on days 0, 7, 14 and weekly thereafter. Asymptomatic shedding of polyomavirus was detected in his urine on days 14 and 21 when the corresponding ALCs were 0 and 300/ml, respectively. Electron microscopy showed the presence of numerous nonenveloped virus particles 40 nm in diameter within the intranuclear inclusion-bearing cells. Cytological examination of urine demonstrated scattered large atypical cells that were round and spindleshaped with a high nuclear/cytoplasmic ratio upon both Sterheimer-Malbin staining and Papanicolaou staining. The bone marrow engrafted on day 24, when the total leukocyte count was 2,100/ml, ANC 600/ml and ALC 1,100/ml. On the same day, the patient developed symptomatic hemorrhagic cystitis with worsening of dysuria and increasing hematuria. Repeated electron microscopy examination of his urine on day 28 was negative for polyomavirus. He was treated with intravenous immunoglobulin (IVIG) 50 mg/kg/day for 3 days. His symptoms subsided on day 34 while his ALC dropped to 400/ml.
As shown in the illustrative cases, in addition to the worsening of underlying diseases, development of antimicrobial resistance, and other noninfectious complications, IRD should be considered an important differential diagnosis for this particular group of patients.
A wide range of microorganisms has been identified in patients with IRD: they include parasites, fungi, mycobacteria, bacteria and viruses. We discussed systemic mycobacterial and fungal infection in the setting of IRD in detail in our previous study [2] . The ectoparasite, Sarcoptes scabiei, is first documented as a manifestation of IRD in the present study. Similar observations to those we noted in our patient were reported in a 4-year-old boy undergoing BMT for acute lymphoblastic leukemia [5] ; however, the authors did not report the case from the perspective of IRD, and the lack of serial hematological profiles made documentation of IRD impossible. A severe form of scabies, called Norwegian or crusted scabies, has been reported in solid organ transplant recipients and AIDS patients [6, 7] . It is characterized by widely distributed psoriasis-like hyperkeratotic crusted nodules and plaques. Although the number of viable mites found on a single patient could be thousands or even millions, there is far less pruritis than scabies in immunocompetent patients and frank inflammation is often lacking. The clinical manifestations of scabies depend on host immunity, as supported by a previous study in which skin was injected intradermally with Sarcoptes extracts in an immunocompetent host. Mononuclear cellular infiltration was detected by serial histological sectioning [8] . Influenza A (H3N2) was documented in nasopharyngeal aspirates by direct antigen detection and viral culture before bone marrow engraftment AEC, absolute eosinophil count; ALC, absolute lymphocyte count; ALL, acute lymphoblastic leukemia; ALP, alkaline phosphatase; AMC, absolute monocyte count; AML, acute myeloid leukemia; ANC, absolute neutrophil count; BMT, bone marrow transplantation; CML, chronic myeloid leukemia; CXR, chest radiography; HC, hemorrhagic cystitis; HSC, hepatosplenic candidiasis; IRD, immunorestitution disease; IS, immunosuppressive; IVIG, intravenous immunoglobulin; MRSA, methicillin-resistant Staphylococcus aureus; NHL, non-Hodgkin lymphoma; SLE, systemic lupus erythematosus
Human strongyloidiasis was also associated with IRD in our study. Strongyloides infection is normally checked by cell-mediated immunity with a predominantly T-helper type 2 response that results in eosinophilia. Overwhelming infection in terms of massive invasion of the gastrointestinal tract and pulmonary tissue may occur in patients with defective T lymphocyte function [9, 10] . Our patient survived the infection during the immunosuppressive phase with few symptoms but developed IRD manifesting as abdominal pain and diarrhea after the dose of steroid was reduced. A progressive rise in the ALC and AEC indicated recovery of the immune system. The occurrence of immunopathological damage during withdrawal of immunosuppressive therapy or bone marrow engraftment, as exemplified in parasitic infestations, is an incidental way to uncover an undiagnosed asymptomatic infectious disease in patients with underlying disease that requires immunosuppression.
Pyogenic bacterial infections are also associated with IRD. We hypothesized that IRD would be confined to patients infected by slow-growing pathogens of low virulence. In actual fact, IRD can also be observed in pyogenic bacterial infection in tissues where antibiotic penetration is problematic. Patient 5 developed pyomyositis following an episode of catheter-related methicillin-resistant Staphylococcus aureus bacteremia. We postulate that the occurrence of pyomyositis was secondary to metastatic deposit of the organism to a microhematoma inside the calf muscle. The microhematoma provided an environment for bacterial multiplication and protection from antibiotic killing. During the neutropenic phase, the patient had nonspecific cramping in the affected area. During subsequent immunorestitution, erythema and swelling developed and evolved to a firm, hard or woody mass. Later, the infiltration of neutrophils produced an area of fluctuance; aspiration at this stage yielded purulent material.
As for viral infection, polyomavirus-related hemorrhagic cystitis in BMT recipients after reduction of steroid in the treatment of graft-versus-host disease or after engraftment constituted 33% of cases in the present study. Reactivation of latent polyomavirus due to impairment of cell-mediated immunity has been demonstrated as one of the etiological factors for hemorrhagic cystitis in seropositive patients undergoing BMT. The occurrence of disease correlated with viruria, and the shedding of virus could precede or coincide with the onset of cystitis [11, 12] . However, the incidence of hemorrhagic cystitis following withdrawal of immunosuppressants or bone marrow engraftment has not been investigated in previous studies [11, 12] . In patient 7, we clearly demonstrated asymptomatic shedding of polyomavirus during the pre-engraftment or immunosuppressive phase. Patients developed symptomatic hemorrhagic cystitis after recovery of the immune system, as indicated by the concomitant increase in ALC either by marrow engraftment or rapid dosage reduction of steroid. Therefore, in addition to cytolytic damage during immunosuppression, the immunopathological manifestation of polyomavirusrelated hemorrhagic cystitis should also be considered as an IRD in certain settings. However, the bleeding diathesis limited our assessment of the histological changes in the urinary bladder during immunosuppression and IRD. In renal transplant recipients, cytopathic changes with nuclear enlargement, irregularity of nuclear contour, and clumping and smudging of the chromatin pattern are the predominant lesions of polyomavirus infection during immunosuppression.
Mononuclear cells and plasma cells may induce extensive interstitial inflammation in the immunorestitution phase, resulting in immunopathological damage [13, 14] . This process may explain why polyomavirus is not detected in urine during symptomatic cystitis. The use of IVIG therapy as an effective immunomodulating agent to control the overwhelming inflammatory response during immunorestitution was anecdotally associated with a decrease in the duration of symptoms by 7 to 10 days in our patients.
In view of the wide spectrum of pathogens involving different organ systems, infectious disease specialists should be vigilant in considering this new diagnostic entity. In the assessment of any immunosuppressed patient with suspected infection, careful review of the regimen of immunosuppressive therapy, close monitoring of serial hematological profiles, and detailed analysis of signs and symptoms before and during immune recovery are crucial in diagnosing IRD. New information will be generated as more cases of IRD are identified. With a better understanding of this disease, prophylactic, pre-emptive and therapeutic regimens for IRD could be established.
